529 filings
Page 4 of 27
8-K
7vts1n60 u9zn4sahga
8 May 23
Syndax Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Business Update
4:07pm
DEFA14A
itykhrd
18 Apr 23
Additional proxy soliciting materials
4:00pm
4
xlyui25phk
12 Apr 23
Syndax Pharmaceuticals / Briggs Morrison ownership change
4:03pm
4
540 fsfhynen
12 Apr 23
Syndax Pharmaceuticals / Neil Gallagher ownership change
4:02pm
3
btqax63ikue bg
12 Apr 23
Syndax Pharmaceuticals / Neil Gallagher ownership change
4:01pm
ARS
rl79k
7 Apr 23
Annual report to shareholders
4:05pm
DEFA14A
lrjiu95
7 Apr 23
Additional proxy soliciting materials
4:02pm
8-K
uqr5ievjpo c8s7b
30 Mar 23
Syndax Pharmaceuticals Announces Appointment of Neil Gallagher, M.D., Ph.D. as President, Head of Research and Development
8:00am
PRE 14A
q7odyfw d8a0m
28 Mar 23
Preliminary proxy
4:15pm
4
yl2ajh3xy olskn
14 Mar 23
Syndax Pharmaceuticals / Briggs Morrison ownership change
4:42pm
S-8
zz8dtp tbf6
28 Feb 23
Registration of securities for employees
4:15pm
8-K
xf6mq tlue2obrdz
28 Feb 23
Syndax Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Business Update
4:06pm
4
azr pcalihtq
17 Feb 23
Syndax Pharmaceuticals / Peter Ordentlich ownership change
6:09pm
SC 13G/A
gs5 ievqwwpjttq5
14 Feb 23
Syndax Pharmaceuticals / Nantahala Capital Management ownership change
4:46pm
SC 13G/A
twdlba485 2m
14 Feb 23
Syndax Pharmaceuticals / Avidity Partners Management ownership change
3:47pm
SC 13G/A
2o3bz4qh to
14 Feb 23
Syndax Pharmaceuticals / Frazier Life Sciences Public Fund ownership change
12:12pm
SC 13G/A
ax55ul27 1fdyh9k01h
14 Feb 23
Syndax Pharmaceuticals / BIOTECHNOLOGY VALUE FUND L P ownership change
11:53am